Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Microbiology

Background:

• Carbapenem-resistant Acinetobacter baumannii (CRAB) is a major cause of healthcare-associated infections, especially in intensive care units (ICUs).
• Cross-transmission between patients and the hospital environment is a key factor in CRAB colonization and infection within ICUs.
• The multidrug resistance of CRAB presents a global challenge for infection control and treatment.

Purpose of the Study:

• To systematically review research on CRAB in ICUs.
• To summarize clinical infections, environmental reservoirs, and resistance mechanisms of CRAB.
• To evaluate current treatment and control strategies for CRAB in ICUs.

Main Methods:

• Literature review of research on CRAB in intensive care units.
• Synthesis of data on clinical infections and environmental reservoirs.
• Analysis of drug resistance mechanisms and homology.
• Evaluation of contemporary treatment and control strategies.

Main Results:

• CRAB is a leading cause of ICU-acquired infections globally.
• Patient-to-environment and environment-to-patient transmission are significant.
• CRAB exhibits extensive multidrug resistance, complicating treatment options.
• Limited therapeutic alternatives highlight the need for robust control measures.

Conclusions:

• Effective prevention and control of CRAB in ICUs require a comprehensive understanding of its epidemiology, transmission, and resistance.
• Further research into CRAB's mechanisms and novel therapeutic approaches is essential.
• Integrated strategies addressing colonization, infection, and environmental control are necessary for managing CRAB in critical care settings.